New pain test battery could speed up drug development

NCT ID NCT07549490

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 34 times

Summary

This pilot study will test a new method to see how two pain medicines, naproxen and pregabalin, work in healthy adults. Up to 25 participants will receive each medicine and a placebo in random order. They will undergo several short, controlled pain tests, like a cold water hand bath and a temporary sunburn-like skin sensitivity. The goal is to see if this testing approach can tell the difference between medicines that work in the brain versus those that reduce inflammation. This study is not expected to help participants directly but may improve how future pain treatments are tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
naproxen and pregabalin
What this could lead to
If successful, this approach could help researchers test new pain treatments more efficiently in early studies.
What could go wrong
This is a very small pilot study in healthy adults, not patients. It is designed to test a method, not to prove any treatment works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.